Cadrenal Therapeutics, Inc. (CVKD)
NASDAQ: CVKD · Real-Time Price · USD
4.760
-0.210 (-4.23%)
At close: Apr 10, 2026, 4:00 PM EDT
4.500
-0.260 (-5.46%)
After-hours: Apr 10, 2026, 7:40 PM EDT
Cadrenal Therapeutics Market Cap
Cadrenal Therapeutics has a market cap or net worth of $11.93 million as of April 10, 2026. Its market cap has decreased by -65.59% in one year.
Market Cap
11.93M
Enterprise Value
7.92M
1-Year Change
-65.59%
Ranking
Category
Stock Price
$4.76
Market Cap Chart
Since the IPO on January 20, 2023, Cadrenal Therapeutics's market cap has decreased from $58.17M to $11.93M, a decrease of -79.49%. That is a compound annual growth rate of -38.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 11.93M | -24.73% |
| Dec 31, 2025 | 15.85M | -38.62% |
| Dec 31, 2024 | 25.83M | 168.05% |
| Dec 29, 2023 | 9.64M | -83.44% |
| Jan 20, 2023 | 58.17M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kairos Pharma | 12.49M |
| Cyclerion Therapeutics | 12.30M |
| Chemomab Therapeutics | 12.02M |
| CytoMed Therapeutics | 11.83M |
| Traws Pharma | 11.83M |
| Cellectar Biosciences | 11.70M |
| GT Biopharma | 11.64M |
| Soligenix | 11.54M |